212 related articles for article (PubMed ID: 2496460)
1. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
Miravet L; Kuntz D
Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
[TBL] [Abstract][Full Text] [Related]
2. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
[TBL] [Abstract][Full Text] [Related]
3. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
O'Donoghue DJ; Hosking DJ
Bone; 1987; 8(4):219-25. PubMed ID: 3128315
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
Davoine GA; Jung A; Courvoisier B
Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
[TBL] [Abstract][Full Text] [Related]
5. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Wimalawansa SJ; Gunasekera RD
Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
[TBL] [Abstract][Full Text] [Related]
6. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Jaeger P; Bischoff-Delaloye A; Burckhardt P
Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
[No Abstract] [Full Text] [Related]
8. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
[TBL] [Abstract][Full Text] [Related]
9. Paget's bone disease treated with diphosphonate and calcitonin.
Hosking DJ; Bijvoet OL; van Aken J; Will EJ
Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
[TBL] [Abstract][Full Text] [Related]
10. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
[TBL] [Abstract][Full Text] [Related]
11. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Nuti R; Turchetti V; Righi G; Vattimo A
Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
[TBL] [Abstract][Full Text] [Related]
12. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
Thiébaud D; Jaeger P; Gobelet C; Jacquet AF; Burckhardt P
Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
Dewis P; Prasad BK; Anderson DC; Willets S
Ann Rheum Dis; 1985 Jan; 44(1):34-8. PubMed ID: 3918513
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
Ravault A; Meunier PJ
Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
[TBL] [Abstract][Full Text] [Related]
17. Procollagen-III peptide serum levels in Paget's disease of the bone.
Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Rashid M; Khairi A; Johnston C
Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
[No Abstract] [Full Text] [Related]
19. Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
Altman RD
Am J Med; 1985 Nov; 79(5):583-90. PubMed ID: 3933343
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
Stein I; Shapiro B; Ostrum B; Beller ML
Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
